Clinical Trial Update: Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL [Phase 2]

View source ↗

Summary

Phase 2 ERASE trial evaluated safety and efficacy of reconstituted HDL (rHDL) CSL-111 in patients with acute coronary syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CSL-111 rHDL (reconstituted high-density lipoprotein (rHDL))

Snippet

Sponsor: CSL Limited | Conditions: Acute Coronary Syndromes | Phase 2 | Status: COMPLETED